Search alternatives:
significant amount » significant impact (Expand Search)
amount decrease » point decrease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 61 - 80 results of 1,000 for search '(( significant amount decrease ) OR ( significant ((side decrease) OR (nn decrease)) ))', query time: 0.47s Refine Results
  1. 61
    Everolimus decreased CD89 deposits in α1<sup>KI</sup>CD89<sup>Tg</sup> mice.

    Everolimus decreased CD89 deposits in α1<sup>KI</sup>CD89<sup>Tg</sup> mice. by Alexandra Cambier (22307216)

    Published 2025
    Save to List
    Saved in:
  2. 62
    Total irrigation amount (m<sup>3</sup>) and average soil water content (%) with rhizosphere zones (0–60 cm depth) during the whole growth period of tomato plants for different treatments.

    Total irrigation amount (m<sup>3</sup>) and average soil water content (%) with rhizosphere zones (0–60 cm depth) during the whole growth period of tomato plants for different trea... by Hongyi Pan (5706971)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 63
    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (<i>TF, Serotransferrin; F2, Prothrombin; CFI, Complement factor I; HPX, Hemopexin; C4A/C4B, Complement C4b; GC, Vitamin D-binding protein; SERPINA7, Thyroxine-binding globulin; CFB, Complement factor B; APOH, Beta-2-glycoprotein 1; NTM, Neurotrimin</i>).

    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 65
    Flow chart on the inclusion and drop out of patients.

    Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Fig 1 -

    Fig 1 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Fig 8 -

    Fig 8 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells.

    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Fig 4 -

    Fig 4 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Fig 9 -

    Fig 9 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Trypan blue dye exclusion assay for cell viability evaluation (% of control).

    Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    Fig 7 -

    Fig 7 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).

    Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    Fig 10 -

    Fig 10 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    Fig 5 -

    Fig 5 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Fig 6 -

    Fig 6 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).

    Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 80
    Everolimus decreased IgA1 deposits in glomeruli of α1<sup>KI</sup>CD89<sup>Tg</sup> mice.

    Everolimus decreased IgA1 deposits in glomeruli of α1<sup>KI</sup>CD89<sup>Tg</sup> mice. by Alexandra Cambier (22307216)

    Published 2025
    Save to List
    Saved in:

Search Tools: